                               SEQUENCE LISTING

<110> THE UNIVERSITY OF TOLEDO
 
<120> IMMUNOSUPPRESSIVE ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR TREG
      CELLS FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE AND 
      ALLOIMMUNE DISORDERS

<130> 62708-US-NP

<140>
<141>

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 135
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Phe Thr Tyr Glu Ile Ala Pro Val Phe Val Leu Leu Glu Tyr Val Thr 
1               5                   10                  15      


Leu Lys Lys Met Arg Glu Ile Ile Gly Trp Pro Gly Gly Ser Gly Asp 
            20                  25                  30          


Gly Ile Phe Ser Pro Gly Gly Ala Ile Ser Asn Met Tyr Ala Met Met 
        35                  40                  45              


Ile Ala Arg Phe Lys Met Phe Pro Glu Val Lys Glu Lys Gly Met Ala 
    50                  55                  60                  


Ala Leu Pro Arg Leu Ile Ala Phe Thr Ser Glu His Ser His Phe Ser 
65                  70                  75                  80  


Leu Lys Lys Gly Ala Ala Ala Leu Gly Ile Gly Thr Asp Ser Val Ile 
                85                  90                  95      


Leu Ile Lys Cys Asp Glu Arg Gly Lys Met Ile Pro Ser Asp Leu Glu 
            100                 105                 110         


Arg Arg Ile Leu Glu Ala Lys Gln Lys Gly Phe Val Pro Phe Leu Val 
        115                 120                 125             


Ser Ala Thr Ala Gly Thr Thr 
    130                 135 


<210> 2
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Glu Arg Ala Asn Ser Val Thr Trp Asn Pro His Lys Met Met Gly Val 
1               5                   10                  15      


Pro Leu Gln Cys Ser Ala Leu Leu Val 
            20                  25  


<210> 3
<211> 83
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Lys Met Phe Pro Glu Val Lys Glu Lys Gly Met Ala Ala Leu Pro Arg 
1               5                   10                  15      


Leu Ile Ala Phe Thr Ser Glu His Ser His Phe Ser Leu Lys Lys Gly 
            20                  25                  30          


Ala Ala Ala Leu Gly Ile Gly Thr Asp Ser Val Ile Leu Ile Lys Cys 
        35                  40                  45              


Asp Glu Arg Gly Lys Met Ile Pro Ser Asp Leu Glu Arg Arg Ile Leu 
    50                  55                  60                  


Glu Ala Lys Gln Lys Gly Phe Val Pro Phe Leu Val Ser Ala Thr Ala 
65                  70                  75                  80  


Gly Thr Thr 
            


<210> 4
<211> 52
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Ala Ile Ser Asn Met Tyr Ala Met Met Ile Ala Arg Phe Lys Met Phe 
1               5                   10                  15      


Pro Glu Val Lys Glu Lys Gly Met Ala Ala Leu Pro Arg Leu Ile Ala 
            20                  25                  30          


Phe Thr Ser Glu His Ser His Phe Ser Leu Lys Lys Gly Ala Ala Ala 
        35                  40                  45              


Leu Gly Ile Gly 
    50          


<210> 5
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Ile Lys Asn Arg Glu Gly Tyr Glu Met Val Phe Asp Gly Lys Pro 
1               5                   10                  15  


<210> 6
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Phe Phe Arg Met Val Ile Ser Asn Pro Ala Ala Thr His Gln Asp Ile 
1               5                   10                  15      


Asp Phe Leu Ile Glu Glu Ile Glu Arg Leu Gly Gln Asp Leu 
            20                  25                  30  


<210> 7
<211> 271
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
Met Asp Met Arg Val Pro Ala Gln Leu Leu Gly Leu Leu Leu Leu Trp 
1               5                   10                  15      


Leu Pro Gly Ala Lys Cys Asp Ile Gln Leu Thr Gln Ser Pro Thr Phe 
            20                  25                  30          


Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser 
        35                  40                  45              


Gln Gly Ile Ser Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys 
    50                  55                  60                  


Ala Pro Asn Leu Leu Ile Tyr Val Ala Ser Thr Leu Gln Ser Gly Val 
65                  70                  75                  80  


Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr 
                85                  90                  95      


Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln 
            100                 105                 110         


Leu Asn Asn Tyr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile 
        115                 120                 125             


Lys Arg Pro Pro Pro Pro Arg Pro Pro Pro Pro Arg Pro Pro Pro Pro 
    130                 135                 140                 


Arg Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Leu Lys Pro Ser 
145                 150                 155                 160 


Glu Thr Leu Ser Leu Thr Cys Ser Val Ser Gly Gly Ser Ile Gly Ser 
                165                 170                 175     


Ser Ser Tyr Ser Trp Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu 
            180                 185                 190         


Glu Tyr Ile Gly Ile Ile Tyr His Ser Gly Arg Thr Tyr Tyr Asn Pro 
        195                 200                 205             


Ser Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln 
    210                 215                 220                 


Phe Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Met Tyr 
225                 230                 235                 240 


Tyr Cys Ala Arg Gln Val Pro Tyr Gln Pro Leu Leu Asp Gly Gly Asn 
                245                 250                 255     


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
            260                 265                 270     


<210> 8
<211> 268
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
Met Ala Trp Thr Val Leu Leu Leu Gly Leu Leu Ser His Cys Thr Gly 
1               5                   10                  15      


Ser Val Thr Ser Tyr Val Leu Thr His Pro Pro Ser Val Ser Val Ala 
            20                  25                  30          


Pro Gly Lys Thr Gly Thr Ile Thr Cys Gly Gly Ser Asn Ile Gly Ser 
        35                  40                  45              


Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Lys Leu 
    50                  55                  60                  


Val Ile Tyr Tyr Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe 
65                  70                  75                  80  


Ser Gly Ser Thr Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Ser Val 
                85                  90                  95      


Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser 
            100                 105                 110         


Gly Asp His Met Val Val Phe Phe Gly Gly Thr Lys Leu Thr Val Leu 
        115                 120                 125             


Pro Pro Pro Pro Arg Pro Pro Pro Pro Arg Pro Pro Pro Pro Arg Gln 
    130                 135                 140                 


Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg Ser 
145                 150                 155                 160 


Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Phe Ser His His Gly 
                165                 170                 175     


Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala 
            180                 185                 190         


Phe Ile Ser Tyr Asp Glu Thr Lys Lys Tyr Tyr Val Lys Ser Val Met 
        195                 200                 205             


Gly Arg Phe Thr Ile Ala Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
    210                 215                 220                 


His Leu Lys Ser Leu Arg Pro Asp Asp Ala Ala Val Tyr Tyr Cys Ala 
225                 230                 235                 240 


Lys Ala Phe Ser Thr Thr Ile Phe Gly Val Val Thr Tyr Gly Met Asp 
                245                 250                 255     


Val Trp Gly Gln Gly Thr Thr Val Ile Val Ser Ser 
            260                 265             


